Latest Breaking News On - Ameritas investment partners inc - Page 12 : comparemela.com

HC Wainwright Trims Cullinan Oncology (NASDAQ:CGEM) Target Price to $28 00

Cullinan Oncology (NASDAQ:CGEM – Get Free Report) had its price objective decreased by stock analysts at HC Wainwright from $29.00 to $28.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target indicates a potential upside of 11.82% from the company’s current price. […]

United statesStifel nicolausZurcher kantonalbank zurich cantonalbankWilliam blairJennifer michaelsonChina universal asset management coAnnandale capitalCullinan oncology incAmeritas investment partners incVontobel holding ltdCullinan oncology company profileCullinan oncologyGet free reportOncology trading downInvestment partnersUniversal asset management

Voyager Therapeutics (NASDAQ:VYGR) Receives Outperform Rating from Oppenheimer

Oppenheimer reissued their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Oppenheimer currently has a $18.00 price objective on the stock. Several other analysts also recently commented on the stock. StockNews.com downgraded shares of Voyager Therapeutics from a buy rating to […]

Tower research capitalChina universal asset management coAmeritas investment partners incVoyager therapeutics incVoyager therapeuticsFree reportModerate buyTherapeutics trading downGet free reportCapital managementInvestment partnersUniversal asset managementResearch capitalVoyager therapeutics daily

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) to Post Q2 2024 Earnings of ($0 14) Per Share, Wedbush Forecasts

Y-mAbs Therapeutics, Inc (NASDAQ:YMAB) to Post Q2 2024 Earnings of ($0 14) Per Share, Wedbush Forecasts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesY mabs therapeutics incSg americas securitiesTower research capitalBailard incAmeritas investment partners incCanaccord genuity groupSecurities exchange commissionChina universal asset management coY mabs therapeuticsFree reportY mabs therapeuticAbs therapeuticsGet free reportUniversal asset managementResearch capital

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN) Raised by B Riley

Q2 2024 EPS Estimates for Viridian Therapeutics, Inc (NASDAQ:VRDN) Raised by B Riley
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesSwiss national bankNeedham companyVanguard group incAmeritas investment partners incMirae asset global investments coViridian therapeutics incAmerican international group incViridian therapeuticsFree reportViridian therapeuticGet free reportInternational groupInvestment partnersNational bankMirae asset global investments

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)

Analysts Offer Predictions for Y-mAbs Therapeutics, Inc s Q2 2024 Earnings (NASDAQ:YMAB)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesBailard incSg americas securitiesY mabs therapeutics company profileTower research capitalChina universal asset management coCanaccord genuity groupAmeritas investment partners incY mabs therapeutics incY mabs therapeuticsFree reportY mabs therapeuticAbs therapeuticsGet free reportGenuity groupUniversal asset management